000			02010 a2200529 4500
005			20250516172402.0
264		0	_c20140512
008			201405s 0 0 eng d
022			_a1940-6215
024	7		_a10.1158/1940-6207.CAPR-13-0172 _2doi
040			_aNLM _beng _cNLM
100	1		_aGrandhi, B Karthik
245	0	0	_aA novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. _h[electronic resource]
260			_bCancer prevention research (Philadelphia, Pa.) _cOct 2013
300			_a1015-1025 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis
650	0	4	_aAspirin _xadministration & dosage
650	0	4	_aCarcinogens _xchemistry
650	0	4	_aCell Line, Tumor
650	0	4	_aCricetinae
650	0	4	_aCurcumin _xadministration & dosage
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aDrug Delivery Systems
650	0	4	_aImmunohistochemistry
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aIsothiocyanates _xadministration & dosage
650	0	4	_aLipids _xchemistry
650	0	4	_aMale
650	0	4	_aMesocricetus
650	0	4	_aNanoparticles _xchemistry
650	0	4	_aNitrosamines _xchemistry
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aProliferating Cell Nuclear Antigen _xchemistry
650	0	4	_aSulfoxides
700	1		_aThakkar, Arvind
700	1		_aWang, Jeffrey
700	1		_aPrabhu, Sunil
773	0		_tCancer prevention research (Philadelphia, Pa.) _gvol. 6 _gno. 10 _gp. 1015-1025
856	4	0	_uhttps://doi.org/10.1158/1940-6207.CAPR-13-0172 _zAvailable from publisher's website
999			_c23122865 _d23122865